SEARCH

SEARCH BY CITATION

References

  • 1
    Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007;62:147152.
  • 2
    Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992;145:160168.
  • 3
    Paggiaro PL, Bacci E, Paoletti P, Bernard P, Dente FL, Marchetti G et al. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest 1990;98:536542.
  • 4
    Saetta M, Maestrelli P, Di Stefano A, De Marzo N, Milani GF, Pivirotto F et al. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992;145:169174.
  • 5
    Lozewisz S, Assoufi BK, Hawkins R, Newman Taylor AJ. Outcome of asthma induced by isocyanates. Br J Dis Chest 1987;81:1422.
  • 6
    Maestrelli P, De Marzo N, Saetta M, Boscaro M, Fabbri L, Mapp C. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Am Rev Respir Dis 1993;148:407412.
  • 7
    Piirilä P, Nordman H, Keskinen H, Luukkonen R, Salo SP, Tuomi T et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate- and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med 2000;162:516522.
  • 8
    Viljanen AA. (ed). Reference values for spirometric, pulmonary diffusing capacity and body plethysmographic studies. Scand J Clin Invest 1982;42 (Suppl. 159):150.
  • 9
    Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault J-C. Lung, volumes and forced ventilatory flows. Eur Respir J 1993;6 (Suppl. 16):540.
  • 10
    Sovijärvi ARA, Malmberg LP, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge: repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993;104:164170.
  • 11
    Taskinen E, Tukiainen P, Renkonen R. Bronchoalveolar lavage: influence of cytologic techniques on the cellular picture. Acta Cytol 1992;36:680.
  • 12
    Sutinen S, Riska H, Backman R, Sutinen SH, Fröseth B. Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. Respir Med 1995;89:8592.
  • 13
    Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951958.
  • 14
    Lehto M, Koivuluhta M, Wang G, Amghalab I, Majuri ML, Savolainen K et al. Epicutaneous natural rubber latex sensitization induces T-helper 2-type dermatitis and stron prohevein-specific IgE response. J Invest Dermatol 2003;120:633640.
  • 15
    Zheng K-C, Nong D-XC, Morioka T, Todoriki H, Ariizumi M. Elevated Interleukin-4 and Interleukin-6 in rats sensitized with toluene diisocyanate. Ind Health 2001;39:334339.
  • 16
    Maghni K, Lemiere C, Ghezzo H, Malo J-L. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004;169:367372.
  • 17
    Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnel W et al. Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005;60:10121018.
  • 18
    Maestrelli P, Di Sefano A, Occari P, Turato G, Milani G, Pivirotto F et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med 1995;151:607612.
  • 19
    Matheson JM, Lemus R, Lange RW, Karol MH, Luster MI. Role of tumour necrosis factor in toluene diisocyanate asthma. Am J Respir Cell Mol Biol 2002;27:396405.
  • 20
    Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH et al. Evidence of a role of tumour necrosis factor α in refractory asthma. N Engl J Med 2006;354:697708.
  • 21
    Rückert R, Brandt K, Braun A, Hoymann H-G, Hoyman H-G, Herz U et al. Blocking IL-15 prevents the induction of allergen-specific T Cells and allergic inflammation in vivo. J Immunol 2005;174:55075515.
  • 22
    Desmedt M, Rottiers P, Dooms H, Firrs W, Grooten J. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol 1998;160:53005308.
  • 23
    Hoontrakoon R, Chu HW, Gardai SJ, Wenzel SE, McDonald P, Fadok VA et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor κB activation. Am J Respir Cell Mol Biol 2002;26:404412.
  • 24
    Mattoli S, Mattoso VL, Soloperto M, Allerga L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991;87:794802.
  • 25
    Mattoli S, Miante S, Calabro F, Mezzetti M, Allegra L. Human bronchial epithelial cells exposed to isocyanates potentiate the activation and proliferation of T cells induced by antigen receptor triggering through the release of IL-1 and IL-6. In: JohanssonSGO, editor. Cellular communication in allergic asthma (Pharmacia Allergy Research foundation 1990 Award Book). Uppsala, Sweden: AW Grafiska, 1990: 423429.
  • 26
    Cluzel M, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, Michel FB et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 1987;80:195201.
  • 27
    Kelly C, Ward C, Stenton CS, Bird G, Hendrick DJ, Walters EH. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 1988;43:684692.
  • 28
    Striz I, Mio T, Adachi Y, Heires P, Robbins R, Spurzem JR et al. Il-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-α. Am J Physiol 1999;277:L58L64.
  • 29
    Tormey VJ, Faul J, Leonard C, Burke CM, Dilmec A, Poulter LW. T-cell cytokines may control the balance of functionally distinct macrophage populations. Immunology 1997;90:463469.
  • 30
    Mapp Ch, Lapa da Silva JR, Lucchini RE, Chitano P, Rado V, Saetta M et al. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am J Respir Crit Care Med 1996;154:201208.
  • 31
    Malo J-L, Cartier A, Ghezzo H, Lagrance M, McCants M, Lehrer SB. Patterns of improvement in spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab. Am Rev Respir Dis 1988;138:807812.
  • 32
    Fletcher Ch, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:16451648.
  • 33
    Anees W, Moore VC, Burge PS. FEV1 decline in occupational asthma. Thorax 2006;61:751755.
  • 34
    Malo JL, Cartier A, Cote J, Milot J, Leblanc C, Paquette L et al. Influence of inhaled steroids on recov3ery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med 1996;153:953960.
  • 35
    Vanacker JG, Palmans E, Pauwels RA, Kips JC. Effect of combining salmeterol and fluticasone on the progression of airway remodelling. Am J Respir Crit Care Med 2002;166:11281134.